0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
The following section summarizes insights on GSK plc DRC's Equity Method Investments:
We've identified the following companies as similar to GSK plc DRC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Equity Method Investments in the financials category include:
This item represents all those non-current investments held by the company, which are accounted for by the equity method of accounting.
GSK reported equity method investments of 120.2 M for the latest quarter ending December 31, 2024 on its balance sheet.
The tables below summarizes GSK’s Equity Method Investments and common size over the last five years:
| Fiscal Year | Equity Method Investments | Assets | % Assets |
|---|---|---|---|
| 2020-12-31 | 497.8 M | 110 B | 0.5% |
| 2021-12-31 | 119 M | 107 B | 0.1% |
| 2022-12-31 | 89.456 M | 72.709 B | 0.1% |
| 2023-12-31 | 70.115 M | 75.22 B | 0.1% |
| 2024-12-31 | 120.2 M | 74.446 B | 0.2% |
The tables below summarizes GSK’s Equity Method Investments and common size over the last four quarters:
| Quarter Ending | Equity Method Investments | Assets | % Assets |
|---|---|---|---|
| 2024-03-31 | 58.046 M | 73.834 B | 0.1% |
| 2024-06-30 | 66.998 M | 73.402 B | 0.1% |
| 2024-09-30 | 108.3 M | 77.611 B | 0.1% |
| 2024-12-31 | 120.2 M | 74.446 B | 0.2% |
The chart above depicts the distribution of equity method investments for companies operating in the Healthcare sector in the Developed economic region. Over 305 companies were considered in this analysis, and 300 had meaningful values. The average equity method investments of companies in the sector is 64.85 M with a standard deviation of 142.8 M.
GSK plc DRC's Equity Method Investments of 120.2 M ranks in the 84.8% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 310 |
| Included Constituents | 300 |
| Min | 1 K |
| Max | 849.5 M |
| Median | 5.823 M |
| Mean | 64.85 M |
| Standard Deviation | 142.8 M |
You can find companies with similar equity method investments using this stock screener.